OPRX Stock News Optimizerx Corporation (OPRX) 1.5100 07/26/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Optimizerx Corporation (OPRX) 1.5100 $OPRX

Merriman Capital Initiates on OptimizeRx Corporation with a Buy Rating
Thomson Reuters ONE - Mon Jul 14, 8:28AM CDT
SAN FRANCISCO - July 14, 2014 - Merriman Capital, Inc. ("Merriman" , a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), announced that it has initiated equity research coverage of OptimizeRx Corporation (OTCQB: OPRX) with a Buy rating and a $3.00 price target.

OPTIMIZERx Corporation Q1 2014 Operating Results
Marketwire - Fri May 16, 12:27PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) announced that it finished the first quarter for 2014 with revenues of $1,317,347 which is a 97% increase over the same first quarter period in 2013, and the organization generated positive net cash of $226,727 from operational activities. The company reported a net loss of $653,315 for the first quarter primarily due to two key factors: 1) a one-time litigation settlement and 2) non cash payment of stock to vendors, former executive and employees.

OPTIMIZERx Corporation Q1 2014 Earnings Call and Announcement of New Chief Financial Officer
Marketwire - Wed May 14, 12:34PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) will be holding its Q1 2014 earnings call on Thursday May 15th at 5:30 PM Eastern Standard Time. The call information for guests is:

OPTIMIZERx Corporation Announces 2013 Year End Results
Marketwire - Mon Mar 31, 11:05AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) announced fourth quarter revenues of $1,810,610, bringing total revenues for fiscal 2013 to $4,957,016 -- an increase of 149% over 2012. OPTIMIZERx Corp. also achieved net income of $215,847 for the year after recognizing a onetime adjustment relative to our cost of goods sold which reflects a change in accounting procedures for reporting revenue share expenses.

Merriman Capital Serves as Sole Manager of OptimizeRx's $10 Million Private Offering
Thomson Reuters ONE - Mon Mar 24, 8:00AM CDT
SAN FRANCISCO, March 24, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR) announced today that it acted as sole manager of the $10 million equity offering for OptimizeRx Corporation (OTCQB: OPRX).

OPTIMIZERx Announces Sponsorship of the CBInet eRx and EHR Conference
Marketwire - Thu Mar 20, 1:46PM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced that it is sponsoring the CBInet eRx and EHR conference March 26 - 27 in Philadelphia, PA.

OptimizeRx Completes Capital Raise to Exercise Securities Redemption Option Agreement With Vicis
Marketwire - Tue Mar 18, 8:33AM CDT
OptimizeRx Corporation (OTCQB: OPRX) announced today it has completed its capital raise of $10 Million and will be exercising the buyout option with Vicis Capital Master Fund to redeem all securities it holds in the Company. This includes all the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, common stock, and all derivative securities, which includes the Series A Warrant to Purchase Common Stock and Series B Warrant to Purchase Common Stock held by Vicis. With these holdings redeemed, we will no longer owe any dividend obligations to Vicis.

OPTIMIZERx Announces Accounting Change
Marketwire - Wed Feb 05, 10:07AM CST
OPTIMIZERx Corp (OTCQB: OPRX) announced its accounting and audit firm has determined a needed adjustment to the accounting policy so that the revenue share expenses are properly accrued each quarter and at the end of the year, versus when they are paid. The method of recording revenue share payments previously aligned with our contractual terms with our platform partners -- which generally required payment 30 days after we received the fees from our sponsored manufacturers in the following quarter. Therefore, for year-end 2012 and each quarter of 2013, there will be a journal entry needed to record the revenue share amounts due on an accrual basis rather than recording these as an expense when they are paid.

OPTIMIZERx Announces Record Preliminary 2013 4th Quarter Results and Update
Marketwire - Wed Jan 22, 6:30AM CST
OPTIMIZERx Corp (OTCQB: OPRX) today announced preliminary 2013 fourth quarter results.

OPTIMIZERx Corporation to Present at Noble Financial Capital Markets' Tenth Annual Equity Conference
Marketwire - Thu Jan 16, 10:31AM CST
OPTIMIZERx Corporation (OTCQB: OPRX) today announced that its Chairman and CEO Mr. David Harrell will present at "TEN"; Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday January 20, 2014 at 9:30 AM Eastern Time.

Renamo Gunmen Strike in Funhaloro
All Africa Global Media - Tue Jan 14, 12:39PM CST
Gunmen of the former rebel movement Renamo killed at least one person in an attack in the early hours of Tuesday morning against Mavume locality, in the southern province of Inhambane, according to a report on Radio Mozambique.

OPTIMIZERx Corporation Executes New Terms to Securities Redemption Option Agreement With Vicis
Marketwire - Fri Jan 03, 9:10AM CST
OPTIMIZERx Corp. (OTCQB: OPRX) announced on January 2, 2014, we executed an Amendment to the Securities Redemption Option Agreement with Vicis Capital Master Fund ("Vicis" to, among other things, extend the term of our option to March 31, 2014 and reduce the price of the option from nine million dollars ($9,000,000) to six million dollars ($6,000,000). The shares and derivative securities include the Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Common Stock, and warrants to purchase shares of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock held by Vicis.

OPTIMIZERx Corporation Announces the Resignation of the Company's Current CEO & Chairman Mr. Shadron L. Stastney
PR Newswire - Fri Sep 20, 5:01PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced that the Company's current Chief Executive Officer, Mr. Shadron L. Stastney, has provided the Board of Directors his resignation for personal reasons. While the Company's Board of Directors has accepted his resignation, effective today, the Company will retain Mr. Stastney's services on a limited basis for advisory work through the end of the year to help the transition with several ongoing projects.

OPTIMIZERx Corporation Announces the Launch of OPTIMIZEHR® to Assist Pharmaceutical Clients with their EHR Strategies & Implementation
PR Newswire - Fri Sep 13, 10:12AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced the launch of OPTIMIZEHR® the company's Electronic Heath Record (EHR) consulting and implementation practice.

OTC Daily Alert Stock Watch - OPTIMIZERx Corp. (OTCQB: OPRX)
WorldStockWire - Fri Aug 16, 6:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com

OPTIMIZERx Corporation Q-2 Earnings Call
Marketwire - Mon Aug 12, 12:59PM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) will be holding its Q-2 earnings call on Wednesday August 14th at 12:00 PM Eastern Standard Time. The call information for guests is:

OPTIMIZERx Corporation Announces Partnership With HealthTronics to Deliver Patient Savings and Support
Marketwire - Tue Jul 30, 7:01AM CDT
OPTIMIZERx Corp. (OTCQB: OPRX) today announced a new alliance, expanding the delivery of its SampleMD solution to an important physician specialty group.

OPTIMIZERx Announces Record Preliminary 2013 Second Quarter Results and Update
Marketwire - Thu Jul 18, 10:54AM CDT
OPTIMIZERx Corp (OTCQB: OPRX) today announced record preliminary 2013 second quarter results.

PDR Network and OPTIMIZERx (SampleMD) Announce Partnership to Deliver Patient Financial Support Programs Within EHR Workflow
PR Newswire - Wed May 29, 1:15PM CDT
PDR Network®, the leading distributor of FDA-approved patient drug safety and support services for electronic health record (EHR) and e-prescribing (e-Rx) platforms, today announced a strategic partnership with OPTIMIZERx Corp. (OTCBB: OPRX), the industry innovator in developing and delivering digital patient financial support technology within the e-prescribing workflow. Under the agreement PDR will bring to market OPTIMIZERx's patent solution for e-Coupons in EHR workflow to the parties' extensive combined EHR network.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading